Obesity and low levels of physical activity impact on cardiopulmonary fitness in older men after treatment for prostate cancer

被引:4
作者
Faithfull, Sara [1 ]
Lemanska, Agnieszka [1 ]
Poole, Karen [1 ]
Aning, Jonathan [2 ,3 ]
Manders, Ralph [4 ]
Marshall, John [5 ]
Saxton, John [6 ]
Turner, Lauren [7 ]
Griffin, Bruce [4 ]
机构
[1] Univ Surrey, Fac Hlth & Med Sci, Sch Hlth Sci, Guildford GU2 7T, Surrey, England
[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[3] Southmead Hosp, Bristol Urol Inst, Bristol, Avon, England
[4] Univ Surrey, Fac Hlth & Med Sci, Dept Nutr Sci, Guildford, Surrey, England
[5] Prostate Canc UK Char, PPI Representat, London, England
[6] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England
[7] Frimley Hlth NHS Fdn Trust, Frimley, Surrey, England
关键词
cardiopulmonary fitness; cardiovascular risk; obesity; older person; prostatic neoplasm; secondary prevention; ANDROGEN-DEPRIVATION THERAPY; CARDIOVASCULAR RISK-FACTORS; METABOLIC SYNDROME; EXERCISE; MANAGEMENT; DISEASE; AGE; RELIABILITY; MORTALITY; DIAGNOSIS;
D O I
10.1111/ecc.13476
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to compare fitness parameters and cardiovascular disease risk of older and younger men with prostate cancer (PCa) and explore how men's fitness scores compared to normative age values. 83 men were recruited post-treatment and undertook a cardiopulmonary exercise test (CPET), sit-to-stand, step-and-grip strength tests and provided blood samples for serum lipids and HbA1c. We calculated waist-to-hip ratio, cardiovascular risk (QRISK2), Charlson comorbidity index (CCI) and Godin leisure-time exercise questionnaire [GLTEQ]. Age-group comparisons were made using normative data. Men > 75 years, had lower cardiopulmonary fitness, as measured by VO2 Peak (ml/kg/min) 15.8 + 3.8 p < 0.001, and lower grip strength(28.6+5.2 kg p < 0.001) than younger men. BMI >= 30kg/m(2) and higher blood pressure all contributed to a QRisk2 score indicative of 20% chance of cardiovascular risk within 10 years (mean: 36.9-6.1) p < 0.001. Age, BMI and perceived physical activity were significantly associated with lower cardiopulmonary fitness. Men with PCa > 75 years had more cardiovascular risk factors compared to normative standards for men of their age. Although ADT was more frequent in older men, this was not found to be associated with cardiopulmonary fitness, but obesity and low levels of physical activity were. Secondary prevention should be addressed in men with PCa to improve men's overall health.
引用
收藏
页数:12
相关论文
共 73 条
  • [1] Adams, 1999, CAN FAM PHYSICIAN, V45, P104
  • [2] The use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic review
    Amireault, Steve
    Godin, Gaston
    Lacombe, Jason
    Sabiston, Catherine M.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2015, 15
  • [3] [Anonymous], 2015, J ONCOL, DOI DOI 10.1155/2015/820403
  • [4] Peak Oxygen Uptake and Cardiovascular Risk Factors in 4631 Healthy Women and Men
    Aspenes, Stian Thoresen
    Nilsen, Tom Ivar Lund
    Skaug, Eli-Anne
    Bertheussen, Gro F.
    Ellingsen, Oyvind
    Vatten, Lars
    Wisloff, Ulrik
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (08) : 1465 - 1473
  • [5] Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival
    Bechis, Seth K.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 235 - 241
  • [6] Body mass index and weight change in men with prostate cancer: progression and mortality
    Bonn, Stephanie E.
    Wiklund, Fredrik
    Sjolander, Arvid
    Szulkin, Robert
    Stattin, Par
    Holmberg, Erik
    Gronberg, Henrik
    Balter, Katarina
    [J]. CANCER CAUSES & CONTROL, 2014, 25 (08) : 933 - 943
  • [7] Quantifying Observational Evidence for Risk of Fatal and Nonfatal Cardiovascular Disease Following Androgen Deprivation Therapy for Prostate Cancer: A Meta-analysis
    Bosco, Cecilia
    Bosnyak, Zsolt
    Malmberg, Anders
    Adolfsson, Jan
    Keating, Nancy L.
    Van Hemelrijck, Mieke
    [J]. EUROPEAN UROLOGY, 2015, 68 (03) : 386 - 396
  • [8] Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?
    Bourke, L.
    Kirkbride, P.
    Hooper, R.
    Rosario, A. J.
    Chico, T. J. A.
    Rosario, D. J.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (01) : 9 - 13
  • [9] Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
    Boyle, H. J.
    Alibhai, S.
    Decoster, L.
    Efstathiou, E.
    Fizazi, K.
    Mottet, N.
    Oudard, S.
    Payne, H.
    Prentice, M.
    Puts, M.
    Aapro, M.
    Droz, J-P
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 116 : 116 - 136
  • [10] Prostate Cancer Treatment and Survival Evidence for Men With Prevalent Comorbid Conditions
    Bradley, Cathy J.
    Dahman, Bassam
    Anscher, Mitchell
    [J]. MEDICAL CARE, 2014, 52 (06) : 482 - 489